By Anora Mahmudova and Barbara Kollmeyer, MarketWatch Strategist says a short-term correction is coming
NEW YORK (MarketWatch) -- U.S. stock prices edged higher, boosted by better-than-expected quarterly results, from the likes of Wal-Mart Stores Inc., and reports of a few high-profile mergers, including Berkshire Hathaway's move to purchase battery maker Duracell.
The Phoenix Companies, Inc. (NYSE:PNX) today announced that its 2014
Annual Meeting of Shareholders will be broadcast live on the company’s
in the Investor Relations section.
Mae® (NYSE:ELLI), a leading provider of innovative on-demand
software solutions and services for the residential mortgage industry,
today announced that it has been named to Software Magazine’s 2014
Software 500, a ranking of the top global software and service
providers, now in its 32 nd year.
Procter & Gamble to record a charge, restate battery earnings after Duracell sale
Procter & Gamble(PG)said on Thursday that it will record a non-cash charge of about 28 cents a share in the current quarter, following its agreement to sell itsto Berkshire Hathaway(BRKA)(BRK/A). The consumer products company added that it will restate its earnings per share from its batteries business to range of 12 cents to 14 cents to discontinued operations for fiscal 2014.
plc (NYSE: MNK) has been informed by the U.S. Food and Drug
Administration (FDA) that the agency has reason to believe that the
company’s methylphenidate hydrochloride extended-release (ER) tablets,
USP (CII) may not be therapeutically equivalent to the category
reference drug Concerta®. As a result, the agency indicated that it has
reclassified Mallinckrodt’s ANDA 202608 for methylphenidate ER dosage
strengths of 27mg, 36 mg and 54 mg from AB (freely substitutable at the
pharmacy level) to BX (presumed to be therapeutically inequivalent). The
agency said that this change was based on the application of its new
Draft Guidance for determining bioequivalence of methylphenidate
hydrochloride products just published on November 6, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.